|
Modulation of urface Markers on BL36 Cells by AzaC |
||||
| Surface marker |
Control |
Treatment AzaC = 5 μM |
AzaC- 10 μM |
AzaC = 50 μM |
|
|
||||
| CD 19 |
94.9 |
88.5 |
86.1 |
58.1 |
| CD 21 |
<20 |
<20 |
<20 |
20.3 |
| CD 23 |
31.5 |
47.6 |
45.2 |
63.8 |
| CD 30 |
<20 |
<20 |
48.4 |
21.5 |
| CD 45 RA |
76.7 |
74.4 |
71.2 |
64.6 |
| CD 45 RO |
21.4 |
35.1 |
33.3 |
38.5 |
| CD 71 |
97.3 |
94.9 |
93.8 |
83.8 |
| CD 138 |
<20 |
23.9 |
23.8 |
24.8 |
|
BL36 cells were exposed with 5 μM, 10 μM and 50 μM AzaC for 4 days. Then cell surface antigens were analyzed by flow cytometry. Values below 20% were considered as negative. In the same conditions, CDs 3 and 10 remain negative, and no variability was observed for CDs 11 a, 18, 25, 38, 44, 48, 54, 58, 77, 80, and 95. | ||||
Poirier et al. Cancer Cell International 2001 1:2 doi:10.1186/1475-2867-1-2 |
||||